Kia Motors Corp is recalling 295,000 US vehicles for fire risks in the engine compartment, which it would inspect for fuel or oil leaks while performing an engine test and making repairs.
The carmakers would also conduct engine replacement, as necessary.
The recall covers some 2012-2013 model year Sorento, 2011-2013 Optima Hybrid, 2012-2015 Forte and Forte Koup, 2012 Sportage, and 2014-2015 Soul.
Last week, Kia and affiliate Hyundai Motor Co agreed to a $210 million civil penalty after failing to timely recall 1.6 million vehicles for engine and bearing issues in 2015 and 2017.
The US National Highway Traffic Safety Administration (NHTSA) said the South Korean automakers inaccurately reported some information regarding the recalls.
The new Kia engine recall was based on an NHTSA investigation in 2019 into non-crash fires in Kia and Hyundai vehicles.
In July, the NHTSA recommended recalls on certain models with a higher fire complaint rate.
Meanwhile, Hyundai recalled 129,000 vehicles in the UIS on Friday due to the potential premature wearing out of connecting rod bearings, which may lead to engine damage and increase fire risks.


Brown-Forman Rejects Sazerac’s $15 Billion Takeover Bid as Family Backs Independence
Unilever Raises 2026 Sales Outlook After Strong Q2 Volume Growth
SK Hynix Q2 Profit Hits Record as AI Memory Chip Demand Fuels Growth
Meta CEO Zuckerberg Opposes U.S. Ban on Chinese AI Models, Warns Against Overregulation
CATL Shares Jump as $5.6 Billion Buyback Signals Confidence in Long-Term Growth
Exosens H1 Profit Beats Forecasts as Defense Demand Drives Growth
Stellantis Sells Free2move Car-Sharing Business to Mutares to Strengthen Core Auto Strategy
Zabka Shares Drop 10% as Seven & i Abandons Investment Plans
TSMC Gradually Restarts Japan Chip Plant After Kumamoto Earthquake
TeamViewer Shares Fall Despite Profit Growth as ARR and Customer Base Decline
Philips Shares Slide 10% Despite Earnings Beat as Weak Orders Raise Growth Concerns
Sika Raises 2026 Sales Outlook After Strong First-Half Results Beat Expectations
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
Tech Stock Positioning Nears Neutral as Investor Rotation Enters Final Phase, Deutsche Bank Says
Barclays Q2 Profit Beats Forecasts as Investment Banking Strength Offsets Higher Costs
Johnson & Johnson Proposes $5.5 Billion Talc Settlement to Resolve U.S. Ovarian Cancer Lawsuits
CXMT IPO Debut in Shanghai Puts $85.5 Billion Chipmaker in Spotlight 



